Searched for
PIRAMAL ENTERPRISES DEMERGER
Vedanta demerger: When will the four new stocks list on BSE, NSE? Here’s what recent demergers indicateMining giant Vedanta is set to demerge four businesses into separate listed entities, with May 1 as the record date. Shareholders will rece...- Piramal Pharma gets locked in lower circuitThe Ajay Piramal entity’s listing follows the demerger from parent Piramal Enterprises (PEL) as part of an exercise to simplify its structu...
- Piramal Pharma lists share on BSE, NSEIn October 2021, the board of directors of PEL approved the demerger of the pharmaceuticals business and simplification of the corporate st...
- Piramal Pharma shares hit 5% lower circuit after listingEarlier last week, the company obtained a go-ahead from the National Company Law Tribunal (NCLT) for the listing of its equity shares. Furt...
- Piramal Pharma to debut on bourses on WednesdayLast Thursday, the company said it has received Sebi’s go-ahead to list its equity shares on domestic stock exchanges
- Buy Piramal Enterprises, target price Rs 1391: ICICI SecuritiesPiramal Enterprises Ltd., incorporated in the year 1947, is a Large Cap company (having a market cap of Rs 25383.08 Crore) operating in Div...
- Piramal Enterprises trades ex-demerger; NBFC business lists at Rs 1,050The record date for the demerger of the pharma business from the finance business has been set as September 1 and stock traded ex-demerger ...
- Piramal shares to trade ex-demerger on TuesdayPiramal Enterprises has secured the approval of the National Company Law Tribunal (NCLT) for the demerger of its pharmaceutical business an...
- Short term traders likely to get disappointed post Reliance AGM: Sandip Sabharwal“I would think that Reliance could languish for some more time and I do not think any demerger is going to happen fast. The new generation ...
- NCLT approves demerger of pharma business from Piramal EnterprisesAjay Piramal, chairperson of PEL said the company is on track to achieve the completion of demerger and separate listing of PPL by the thir...
- Piramal Enterprises Q2 results: Net profit drops by 32% due to DHFL costThe non-banking finance company incurred an exceptional cost of Rs 153 crore, which is primarily on account of DHFL. Without this, the net ...
- Piramal board okays demerger of pharma, financial services operationsThe amalgamation of PHL Fininvest Private Limited with PEL will create a listed non-banking financial services (NBFC) entity. The merged ho...
- Piramal Enterprise gets board nod for demerger and listing of pharma businessThe pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma Ltd (PPL), the gro...
- Piramal Enterprises board approves scheme for pharma biz demergerThe pharmaceuticals business will get demerged from Piramal Enterprises (PEL) and consolidated in Piramal Pharma, Piramal Enterprises said ...
- Piramal Enterprises cuts gains as company clears the airThe company made its stand clear through a communication to exchanges.
- Piramal Enterprises to demerge healthcare, financial servicesPiramal Enterprises is growing largely organically with a CAGR of 17 per cent over last the five years.
- Piramal Enterprises decides to demerge its healthcare and financial services businessesThe Piramal Group, which was primarily a pharmaceutical business, has diversified into areas such as finance, private and real estate fundi...
- Piramal to demerge healthcare & financial services businessAjay Piramal-led Piramal Enterprises is looking to demerge its healthcare and financial services businesses to grow unrelated divisions sep...
- Piramal Enterprises Q1 net profit at Rs 4.08 croreDiversified company Piramal Enterprises today reported a consolidated net profit of Rs 4.08 crore for the quarter ended June 30, 2012.
- Emkay puts buy on Piramal Life Science; target Rs 270Emkay Global Financial Services has initiated ‘buy’ on Piramal Life Sciences for a target price of Rs 270.
Load More
